In practice that is usually 1 to 1.5 inches for an adult
Nausea is particularly prevalent, affecting approximately 15-20% of patients taking Ozempic and up to 44% of patients taking Wegovy during clinical trials
The strongest evidence-based case for GLP-1 therapy is in patients who have both overweight or obesity and established cardiovascular disease
9-11 This review should be concluded with the acknowledgement of an important limitationthese trials had a relatively short duration
He was sharing a patient story about how taking a GLP-1 gave them relief from the food noise, and I remember thinking, Thats exactly what Ive been fighting my entire life! I had already lost 100 pounds, twice , through diet and exercise, but I was still struggling with the last 40 pounds I wanted to lose to reach a healthier weight for my body
Drink the provided fluids and have a small snack